vimarsana.com

இருந்தது தொடர்புடையது உடன் மேம்பாடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pilot Study Finds Triglyceride Lowering Drug Vascepa May Improve COVID-19 Symptoms

December 17, 2020 Research suggests that the prescription drug Vascepa may help treat the symptoms of mild to moderate COVID-19.  Everyday Health While frontline workers are beginning to get the first round of COVID-19 vaccines, experts agree it will be months before everyone will be protected. In the meantime, researchers continue to look for ways to treat people who have contracted the novel coronavirus. A new Canadian study presented as a late-breaking clinical trial on December 12 at the National Lipid Association Conference found that the prescription drug Vascepa (icosapent ethyl) shows some promise for treating the symptoms of mild to moderate COVID-19. Those treated with the drug had a 25 percent reduction in the inflammatory biomarker high sensitivity C-reactive protein (CPR), and COVID-19 symptoms were significantly reduced compared with patients who were untreated.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.